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Purpose: The purpose of this study is to measure the internal radiation dose using human 
blood sample. In the literature, there is no process that allows the direct measurement of the 
internal radiation dose received by a person. This study has shown that it is possible to 
determine the internal radiation doses in human blood exposed to internal or external ionizing 
radiation treatment both directly and retrospectively. 
Methods: In this study, the optical stimulated luminescence (OSL) technique was used to 
measure the total dose (paleodose) from the blood sample. OSL counts from the waste blood 
of the patient injected with a radiopharmaceutical for diagnostic or treatment purposes and 
from a blood sample having a laboratory-injected radiation dose were both used for 
measurements. The decay and dose-response curves were plotted for different doses. The 
doses received by different blood aliquots have been determined by interpolating the natural 
luminescence counts to the dose-response curves. In addition, optically stimulated 
luminescence counts from a healthy blood sample exposed to an external radiation source 
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were measured. The blood aliquots were given 0, 1, 2, 3, 4, 5, 10, 15, 20, 25, 50, 100 and 
200Gy beta doses and their decay and dose-response curves were plotted. 
Results: The internal dose received by the blood aliquots injected with radioisotope was 
determined by interpolating the natural luminescence counts to the dose-response curve. The 
internal dose values were found as ~0.46Gy for 1-5Gy dose range and ~0.51Gy for 0.143-
0.848Gy dose range. The blood aliquots from a healthy person were exposed to different 
external laboratory doses. The luminescence counts were found to be relatively low for the 
doses smaller than 10Gy while they were measured considerably high for doses greater than 
10Gy. The internal dose values corresponding to 10Gy laboratory dose from the aliquots 
exposed to external radiation were found as 10.94±3.30Gy for Disc3 and 10.79±3.28Gy for 
Disc1.  
Conclusions: This study shows that the dose received by a person can be measured directly, 
simply and retrospectively by using only a very small amount of blood sample. The results 
will have important ramifications for the medicine and healthcare fields in particular. Also, 
the dose thought to be the cause of frequent cancer cases in certain regions can be determined 
by taking small blood samples and the necessary precautions can then be taken. 
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1. INTRODUCTION 
It is common knowledge that ionizing radiation is being used more and more in the field of 
medicine. Patients are exposed to internal radiation doses in various ways such as  ingestion 
or injection for diagnosis or treatment of diseases. The book written by Martin
1
 states: “An 
internal radiation dose can occur due to inhalation or ingestion of radionuclide, a direct 
injection for diagnosis or treatment of disease, a puncture wound, or skin absorption. Internal 
radiation doses cannot be measured; they must be calculated based on an estimated ⁄ measured 
intake, an estimated ⁄ measured quantity in an organ or an amount eliminated from the body”.  
 It is well known that the dose is defined as the deposited energy per unit mass of 
target. The calculations of internal doses are based on certain assumptions such as the 
homogeneously distrubuted activity on the target organ or the target organ being treated as the 
source organ. In medical applications the cumulative activity is defined using the values for 
the activity and time, and the absorbed dose is given as,  D=A×S (Target←Source), where, A 
is the cumulative activity, S (Target←Source) represents the combination of energy deposit 
parameters with the transformation constants; the S-value is fixed for a given radionuclide.
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This process does not base on a direct  measurement  to determine the internal radiation doses 
received by a person. The knowledge of the dose that will be given to the target volume is the 
most important factor affecting the success of therapy when using ionizing radiation for 
diagnosis and / or treatment.   
In the field of radiation therapy, dose that will be given to the patient is planned using 
a treatment planning system. But what about the dose already received by the patient?  It has 
not been possible to answer this question accurately. The retrospective dosimeter method is 
needed to determine the dose already received by patient.  
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 The optically stimulated luminescence (OSL) technique was firstly introduced by 
Huntley et al. for dosimeter
2
. This technique is based on measuring the luminescence signal 
from the sample that has been exposed to ionizing radiation. The luminescence concepts have 
been described using an energy band model of solids and applied to retrospective dosimetry.
3-
5
The ionizing radiation produces electron-hole pairs in the solid structure and thus they 
trapped. Under stimulation of light the electrons may free themselves from the traps and get 
into the conduction band. From the conduction band they may recombine with holes trapped 
in hole-traps. The luminescence signal is proportional to the number of trapped electrons and 
the number of trapped electron is proportional to the dose of ionizing radiation absorbed by 
the material. The OSL technique has been used in radiation dose measurements.
6-10
 Tanır and 
Bölükdemir8, Tanır et al.9, Spooner et al.11 and Polymeris et al.12 showed that the 
luminescence signal from halides such as NaCl and KCl are very bright. However, to the best 
of our knowledge, no work has been reported on the direct  measurement of internal radiation 
doses using blood sample. 
In this study, OSL dosimetry technique which is becoming increasingly important in 
the field of radiation physics, was used to determine the retrospective dose measurements. 
OSL measurements were performed using constant stimulation intensity, which is called 
continuous-wave OSL (CW-OSL). CW-OSL is the simplest and the most straightforward 
process. 
2. MATERIALS AND METHOD 
 2.A. Experimental  
 The luminescence signal from blood sample was read using the ELSEC 9010 OSL 
system developed by Spooner et al.
13
 and also the Risø TL/OSL-DA-20 automatic system 
(Nutech, Technical University of Denmark). The photomultiplier (PM) tube used in the 
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experiments are bialkali EMI 9235QA for ELSEC 9010 and EMI 9235QB15 for Risø 
TL/OSL systems. The total power from the LEDs (blue, 470nm) in the Risø TL/OSL-DA-20 
system is approximately 80mW/cm
2
 at the sample position. A Hoya U-340 filter is 
incorporated to minimize the amount of directly scattered blue light reaching the detector 
system. 
 Blue-Green light LEDs (420-550nm) from Osram were installed in the ELSEC 9010 
OSL system by Nuclear Sciences Institute of Ankara University which have a power output of 
about 6cd at 39mA. A long-pass Schott UG11 filter was fitted in front of the blue LEDs to 
minimize the amount of directly scattered blue light reaching the PM photocathode. In 24 
LEDs, the total power delivered to the sample was measured as 24mW/cm
2
 at a distance of 
16mm. The irradiator has 1.48GBq 
90
Sr/
90
Y beta source. The dose rate at the sample position 
is approximately 0.143Gy/s for both systems.  
 All the samples were settled onto 1cm diameter Al discs using paraffin oil and 
protected from light between the irradiation and OSL measurements. All of the blood aliquots 
prepared was 3mg. The blood aliquots were left at RT at our institution for 72 hours. All 
signals were measured at room temperature (RT) and under red light. None of the aliquots 
was preheated.  
2. A.1. Experiment 1 
 The waste blood sample of a patient undergoing radioisotope treatment was taken 
from the Nuclear Medicine Center. For dose calculation, the natural luminescence counts 
(from aliquots not given doses in OSL laboratory) were measured. The background counts 
were subtracted from the total luminescence counts. Natural luminescence measurements 
were repeated using different aliquots. One of the aliquots was exposed to four different 
laboratory radiation doses ranging from 1Gy to 5Gy using 
90
Sr-
90
Y beta source. The other 
aliquot was given five different laboratory radiation doses in the 0.143-0.848Gy range. The 
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algorithm for the measurements was as follows: the natural luminescence counts were 
measured for 50s; the bleached aliquot was exposed to dose and its luminescence counts were 
measured for 50s.  
2. A.2. Experiment 2 
 The blood serum that was not subjected to radioisotope treatment was put into a tube 
1cm in diameter and 3.5cm length. 1.530 ± 0.103mCi of 99mTc was injected into the tube. The 
mixture was left at RT for 72 hour in the dark room. The serum with 
99m
Tc was dropped onto 
the Al discs as follows; one drop on one of the discs, two drops on another disc, three drops 
and five drops on the others. These aliquots were dried at RT by shielding from sunlight. The 
activity of one drop was calculated assuming uniform distribution. The activities of the 
aliquots were 17μCi, 34μCi, 51μCi and 85μCi. The integrated luminescence counts were 
measured for 50s. 
2. A.3. Experiment 3 
 The aliquots from the healthy blood sample were prepared by dropping onto 1cm 
diameter Al discs. Four aliquots from the blood sample were prepared with care as identical 
as possible. They were left at RT for 72 hours by shielding from sunlight. The signals from 
the aliquots were measured before laboratory irradiation (for 0Gy). Then 1, 2, 3, 4, 5, 10, 15, 
20, 25, 50, 100 and 200Gy laboratory beta doses were given to each aliquot and the 
luminescence counts were measured. The algorithm for measurements was same as in the 
Experiment 1. 
3. RESULTS and DISCUSSION 
In this study, three different experiments were carried out. Although the sample preparation is 
similar for all of them the algorithms of dosing are different. 
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3. A. The waste blood sample from a patient  
 The natural OSL decay curves from two different aliquots prepared from the waste 
blood sample from a patient (Section 2.A.1) were shown in Figure 1.  Figure 1 indicates that 
the blood aliquots include the given ionizing radiation and that it can be possible to measure 
luminescence signal from the blood sample which received a radiopharmaceutical. If such a 
curve could have  not been obtained then one could  not be able to use the OSL technique  to 
measure the dose received by the sample. The decay curves from the aliquots irradiated by 1-
5Gy and 0.143-0.848Gy laboratory doses were shown in Figure 2 and Figure 3 respectively.  
The bleaching time was considered about 3s from these decay curves.  
 The graphs in Figure 1, 2 and 3 are sufficient to prove that it is possible to determine 
the paleodose using a blood sample given radioisotopes treatment. That is, these graphs show 
that the luminescence counts increase with increasing laboratory dose and the internal 
radiation dose can directly be determined using the OSL technique.  
 
FIG.1. OSL decay curves (natural counts) from two different blood aliquots injected with a 
radiopharmaceutical in nuclear medicine center.  
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FIG.2. Decay curves from the blood aliquot received radioisotope treatment for laboratory 
doses of 1, 2, 3 and 5Gy. 
 
FIG.3. Decay curves from the blood aliquot taken radioisotope treatment for laboratory doses 
of 0.143-0.858Gy range. 
The dose-response graphs corresponding to the decay curves in Figure 2 and Figure 3 
were seen in Figure 4 and Figure 5. The dose-response graph obtained using the maximum 
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Figure 4). When the dose-response graph was plotted using the integrated counts (for 3s) the 
equation obtained was y= 2189.2 x – 659.8; r2 = 0.9978 for Figure 4. The internal dose from a 
blood sample can be determined using dose-response equation by interpolating the natural 
luminescence count on the dose-response graph. The natural luminescence count was 
measured as 33 for 0.2s and 347 for 3s. By using these values the internal doses from Figure 4 
were found to be 0.4590Gy and 0.4598Gy respectively. The natural luminescence count was 
measured as 515 for 0.2s and 2068 for 3s from the other aliquot. When the same calculations 
were made by making use of Figure 5 the internal doses were found as 0.22Gy for the 
maximum counts and 0.51Gy for the integrated counts.  
 
FIG.4. The dose-response curves using integrated counts (circle) and maximum  counts 
(square) for 1-5Gy range. 
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FIG.5. The dose-response curves using integrated counts (circle) and maximum counts 
(square) for 0.143-0.848Gy range. 
  Figure 4 and Figure 5 show that the internal dose can be determined by considering 
either the integrated counts or the maximum counts. The dose response curves for each decay 
curve were found to be linear for blood aliquots. The difference between the slopes of the 
dose response curves for different doses is attributed to the difference in blood aliquots.  
 3. B. The blood serum 
 The decay curves from the blood serum aliquots (Section 2.A.2) were shown in Figure 
6. The integrated luminescence signals were corrected by applying the mass normalization. 
Since four different aliquots were used and the activities given to each of them was different. 
The activity-response curve corresponding to decay-curves was shown in Figure 7.  
 
y = 3645x + 212.87 
R² = 0.9936 
y = 2392.6x - 18.667 
R² = 0.995 
0 
500 
1000 
1500 
2000 
2500 
3000 
3500 
4000 
0 0.2 0.4 0.6 0.8 1 
C
o
u
n
ts
 (
a
.u
) 
Dose (Gy) 
11 
 
 
FIG. 6.  The decay curves from aliquots injected to 17µCi, 34µCi, 51µCi and 85µCi. 
  
FIG.7. The activity-response curve using the data in Figure 6. 
 The linearity of Figure 7 has been realized by making mass normalization. It is seen 
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it is recommended to use blood serum for internal dose determination rather than to use whole 
blood.  
3. C. The blood sample exposed to external radiation beam 
 In Figure 8 the luminescence signals from the blood aliquot (Section 2.A.3) that was 
not exposed to a laboratory dose and the decay curve for the same aliquot given 50Gy 
laboratory dose were seen. Healthy blood has no luminescence signal (Figure 8a). Figure 8b 
shows that it is possible to measure the luminescence counts from blood exposed to external 
radiation. The signals were integrated in 5s.  
 
FIG.8. (a) The background level signals from the blood aliquot that not exposed to external 
radiation dose. (b) The luminescence decay curve from the blood aliquot exposed to 50Gy 
external radiation dose.  
 Then, the decay curves from two aliquots (Disc 1 and Disc 3) for different radiation 
doses were obtained and shown in Figure 9 and Figure 10.  Because the luminescence counts 
were relatively weak up to 10Gy, the decay curves were plotted for doses higher than 10Gy. 
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The maximum luminescence counts are 26, 38, 52, 85, 100, 113 corresponding to 0, 1, 2, 3, 4, 
5Gy doses respectively.  
 The dose-response curves obtained using signals from the two aliquots were plotted in 
Figure 11 and Figure 12. The luminescence counts from Disc 1 were measured as 
467counts/5s when 10Gy dose was given. By inserting this value in the Equation in Figure 11 
the dose was calculated as 8.54±2.92Gy.  The luminescence count from Disc 3 was measured 
as 459counts/5s and then inserted it to Equation in Figure 12. The dose was calculated as 
8.01±2.83Gy.  
 
FIG. 9. The decay curves from blood aliquot (Disc 1) for different doses. 
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FIG.10. The decay curves from blood aliquot (Disc 3) for different doses. 
 
 
FIG.11. Dose-response curve for Disc 1. The count for 10Gy was not included in the curve. 
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FIG.12. Dose-response curve for Disc 3. The count for 10Gy was not included in the curve. 
 
FIG.13. The dose-response graph for the low doses (1-5Gy) for Disc 3.  
 Figure 13 and Figure 14 were also plotted for 1-5Gy dose range for Disc 3 and Disc 1 
respectively since the dose-response graph was expected to be linear for low doses.  The dose 
value was calculated as 11.02±3.30Gy for Disc 3 from y=36.8x + 53.4 by inserting 
459Counts/5s corresponding to 10Gy. The dose value was calculated as 10.79±3.28Gy for 
Disc 1 from y=18.69x + 22.29 by inserting 224Counts/0.2s corresponding to 10Gy. 
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FIG.14. The dose-response graph for the low doses (1-5Gy) for Disc 1.  
  
4. CONCLUSION 
This study shows that the ionizing radiation received by a person can be measured 
directly and retrospectively using only a very small amount of blood sample by OSL 
technique. This process should be applied before the biological life of radioisotopes and/or 
immediately after external irradiation. This application of OSL has the importance in 
preventing patients being given the wrong dose when undergoing treatment. Besides the dose 
thought to be the cause of frequent cancer cases in certain regions can be determined and the 
necessary precautions can then be taken.  It can be finally concluded that this application of 
OSL will be very illuminating in important fields such as health care, medicine and radiation 
protection. 
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